Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP469566.RAcJurgL6MUEJurVnxpPp1XIWrdtrcjhcREhclIE7NKGY130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP469566.RAcJurgL6MUEJurVnxpPp1XIWrdtrcjhcREhclIE7NKGY130_assertion type Assertion NP469566.RAcJurgL6MUEJurVnxpPp1XIWrdtrcjhcREhclIE7NKGY130_head.
- NP469566.RAcJurgL6MUEJurVnxpPp1XIWrdtrcjhcREhclIE7NKGY130_assertion description "[We previously demonstrated that mucosal Hsp60 decreases in UC patients treated with conventional therapies (mesalazine, probiotics), suggesting that this chaperonin could be a reliable biomarker useful for monitoring response to treatment, and that it might play a role in pathogenesis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP469566.RAcJurgL6MUEJurVnxpPp1XIWrdtrcjhcREhclIE7NKGY130_provenance.
- NP469566.RAcJurgL6MUEJurVnxpPp1XIWrdtrcjhcREhclIE7NKGY130_assertion evidence source_evidence_literature NP469566.RAcJurgL6MUEJurVnxpPp1XIWrdtrcjhcREhclIE7NKGY130_provenance.
- NP469566.RAcJurgL6MUEJurVnxpPp1XIWrdtrcjhcREhclIE7NKGY130_assertion SIO_000772 22297444 NP469566.RAcJurgL6MUEJurVnxpPp1XIWrdtrcjhcREhclIE7NKGY130_provenance.
- NP469566.RAcJurgL6MUEJurVnxpPp1XIWrdtrcjhcREhclIE7NKGY130_assertion wasDerivedFrom befree-20150227 NP469566.RAcJurgL6MUEJurVnxpPp1XIWrdtrcjhcREhclIE7NKGY130_provenance.
- NP469566.RAcJurgL6MUEJurVnxpPp1XIWrdtrcjhcREhclIE7NKGY130_assertion wasGeneratedBy ECO_0000203 NP469566.RAcJurgL6MUEJurVnxpPp1XIWrdtrcjhcREhclIE7NKGY130_provenance.